A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This study will evaluate efficacy, safety and tolerability of Avastin versus placebo added to
a chemotherapeutic regimen in patients with metastatic pancreatic cancer. The anticipated
time of study treatment is until confirmed evidence of disease progression, and the target
sample size is 500+ individuals.